CRAMP analog having potent antibiotic activity without hemolytic activity

Protein Pept Lett. 2002 Aug;9(4):275-82. doi: 10.2174/0929866023408643.

Abstract

CRAMP-18 is an 18-residue functional region, corresponding to residues 16-33 of a mouse-derived antibiotic peptide CRAMP. To develop novel antibiotic peptides possessing strong antibiotic activity against bacterial, fungal and tumor cells without hemolytic activity, three analogs of CRAMP-18 were synthesized containing either Leu- or Lys-substitution. Leu-substitution ([L(1, 8)]-CRAMP-18) in the hydrophobic helix face of CRAMP-18 induced a dramatic increase in antibiotic activity without a significant increase in hemolytic activity. Lys-substitution ([K(2, 13)]-CRAMP-18 or [K(9, 16)]-CRAMP-18) in the hydrophilic helix face produced a smaller response. Therefore, [L(1, 8)]-CRAMP-18 may be an attractive candidate for developing novel peptide antibiotics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Anti-Bacterial Agents / chemical synthesis*
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology
  • Antifungal Agents / chemical synthesis*
  • Antifungal Agents / pharmacology
  • Antimicrobial Cationic Peptides*
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Aspergillus fumigatus / drug effects
  • Bacteria / drug effects
  • Cathelicidins
  • Circular Dichroism
  • Erythrocytes / drug effects
  • Hemolysis
  • Humans
  • Mice
  • Molecular Sequence Data
  • Peptides / chemical synthesis*
  • Peptides / chemistry
  • Peptides / genetics
  • Peptides / pharmacology
  • Proteins / chemistry*
  • Proteins / genetics
  • Tumor Cells, Cultured

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Antimicrobial Cationic Peptides
  • Antineoplastic Agents
  • Cathelicidins
  • Peptides
  • Proteins